Avatar

Ronald Gangnon

Professor of Biostatistics

University of Wisconsin-Madison

Biography

I am a Professor in the Department of Biostatistics and Medical Informatics and the Department of Population Health Sciences in the School of Medicine and Public Health at the University of Wisconsin-Madison. I have an affiliate appointment in the Department of Statistics.

I grew up in Duluth, Minnesota. I graduated from East High School in 1988. I received a BA in Mathematics and Economics in 1992 from the University of Minnesota-Duluth and an MS in Statistics in 1994 and a PhD in Statistics with emphasis in Biostatistics in 1998 from the University of Wisconsin-Madison. My PhD advisor was Murray Clayton.

I was a research scientist in the Statistical Data Analysis Center (SDAC) in the Department of Biostatistics and Medical Informatics at the University of Wisconsin-Madison, 1998-2005. I joined the faculty with a joint appointment in the Department of Biostatistics and Medical Informatics and the Department of Population Health Sciences in 2005.

I am an applied biostatistician focusing on problems in clinical and epidemiologic research. Current methodologic areas of interest include (1) multi-state models for incidence, progression and regression of ocular (and other) diseases, (2) small area estimation problems, particularly ranking, (3) spatial and spatio-temporal modeling, particularly cluster detection and high-dimensional variable selection and (4) age-period-cohort modeling.

Outside of the office, I’m an avid cyclist. You can check out my recent rides on Strava. I’m also a big movie fan. You’ll definitely see me at the Wisconsin Film Festival, one of my favorite events every year, and you can see lists of my favorite films and what I’ve been watching recently on Letterboxd.

Interests

  • Spatial and Spatio-Temporal Modeling
  • Age-Period-Cohort Models
  • Ranking
  • Multi-State Models

Education

  • PhD in Statistics (emphasis in Biostatistics), 1998

    University of Wisconsin-Madison

  • MS in Statistics, 1994

    University of Wisconsin-Madison

  • BA in Mathematics and Economics, 1992

    University of Minnesota-Duluth

Publications

Gastroesophageal Reflux, Sleep-Disordered Breathing, and Outcomes in Patients With Idiopathic Pulmonary Fibrosis

Background Gastroesophageal reflux disease (GERD) and obstructive sleep apnea (OSA) may negatively impact idiopathic pulmonary fibrosis (IPF), but data on their concurrent contributions are lacking. We aimed to test the contributions of GERD and sleep-disordered breathing (SDB) to IPF outcomes. Methods We performed a cross-sectional, exploratory study on subjects with IPF. Clinically established GERD diagnosis, questionnaires (Nocturnal GERD Symptom Severity and Impact Questionnaire [N-GSSIQ], the NIH Patient-Reported Outcomes Measurement Information System [PROMIS] sleep impairment and fatigue scales, and Short Form-36 [SF-36]), full pulmonary function tests (PFT), six-minute walk test (6MWT), and nocturnal polysomnography (PSG) were obtained. Results Among n = 24 subjects, 17 (71%) had clinically diagnosed GERD. N-GSSIQ scores indicated a nocturnal burden, which was adversely related to sleep impairment (p = 0.010) and daytime fatigue (p = 0.001), tiredness (p = 0.026) and SF-36 social functioning (p = 0.005), energy/fatigue (p = 0.015), pain (p = 0.030), and health change in the prior year (p = 0.035). From PSG, GERD correlated with worse sleep architecture (GERD diagnosis, all p < 0.05) and periodic leg movements index (PLMI) (N-GSSIQ, p = 0.02). GERD was not associated with pulmonary or exercise physiology. Overall, apnea–hypopnea index (AHI) was (median [25% quartile, 75% quartile]) 18.2 (8.1, 27.8)/h, and 19 (79%) subjects had OSA (AHI ≥ 5/h), with most (15/19 [79%]) having moderate or severe disease. SDB measures adversely related to gas exchange and distance walked (all p < 0.05). Conclusions A nocturnal burden of GERD was detected and related to sleep disruption, including PLMs, and to daytime complaints. SDB/OSA, of a severity known to have significant health consequences, was common; it was adversely related to pulmonary diffusion and exercise capacity. These findings call for comprehensive, early evaluation of GERD and OSA for improved IPF outcomes.

Trends Over Time in the Prevalence of Autism by Adaptive and Intellectual Functioning Levels

The autistic community is a large, growing, and heterogeneous population, and there is a need for improved methods to describe their diverse needs. Measures of adaptive functioning collected through public health surveillance may provide valuable information on functioning and support needs at a population level. We aimed to use adaptive behavior and cognitive scores abstracted from health and educational records to describe trends over time in the population prevalence of autism by adaptive level and co-occurrence of intellectual disability (ID). Using data from the Autism and Developmental Disabilities Monitoring Network, years 2000 to 2016, we estimated the prevalence of autism per 1000 8-year- old children by four levels of adaptive challenges (moderate to profound, mild, borderline, or none) and by co-occurrence of ID. The prevalence of autism with mild, borderline, or no significant adaptive challenges increased between 2000 and 2016, from 5.1 per 1000 (95% confidence interval [CI]: 4.6–5.5) to 17.6 (95% CI: 17.1–18.1) while the prevalence of autism with moderate to profound challenges decreased slightly, from 1.5 (95% CI: 1.2–1.7) to 1.2 (95% CI: 1.1–1.4). The prevalence increase was greater for autism without co-occurring ID than for autism with co-occurring ID. The increase in autism prevalence between 2000 and 2016 was confined to autism with milder phenotypes. This trend could indicate improved identification of milder forms of autism over time. It is possible that increased access to therapies that improve intellectual and adaptive functioning of children diagnosed with autism also contributed to the trends.

Spatial and spatio-temporal cluster detection via stacking

Patterns in disease across space and time are important to epidemiologists and health professionals because they may indicate underlying elevated disease risk. In some cases, elevated risk may be driven by environmental exposures, infectious diseases or other factors where timely public health interventions are important. The spatial and spatio-temporal scan statistics identify a single most likely cluster or equivalently select a single correct model. We instead consider an ensemble of single cluster models. We use stacking, a model-averaging technique, to combine relative risk estimates from all of the single cluster models into a sequence of meta-models indexed by the effective number of parameters/clusters. The number of parameters/spatiotemporal clusters is chosen using information criteria. A simulation study is conducted to demonstrate the statistical properties of the stacking method. The method is illustrated using a dataset of female breast cancer incidence data at the municipality level in Japan.

Comprehensive Planning for Healthy Eating and Active Living: A Systematic Assessment from Wisconsin

Comprehensive plans can promote healthy eating and active living (HEAL). Using a validated scorecard, we assessed HEAL-promoting components in 116 Wisconsin comprehensive plans. Few plans explicitly address healthy food access or public health. Higher HEAL scores are positively associated with population size, recent plan adoption, a consultant plan author, Democratic voting, and whether “housing and transit” is a designated local health priority. Our findings show that, in Wisconsin, municipal comprehensive plans promote HEAL in a limited and aspirational way, often without actionable policies. Strategies to improve HEAL-oriented planning practice include partnering with public health departments and additional training for planners.

Self-efficacy for cancer self-management in the context of COVID-19: a cross-sectional survey study

Purpose For cancer survivors, self-efficacy is needed to manage the disease and the effects of treatment. The COVID-19 pandemic disrupted cancer-related healthcare, which may have impacted self-management self-efficacy. We investigated self-efficacy reported by cancer survivors during COVID-19, including associations with healthcare disruptions, distress, and general health. Methods Between 2020 and 2021, 1902 individuals aged 18–80 years with a recent cancer diagnosis completed a survey regarding the effects of COVID-19 on healthcare, self-efficacy for managing cancer and social interactions, cancer-related distress, and perceived general health. Linear and logistic models estimated odds ratios and 95% confidence intervals (CIs) between self-efficacy scores, healthcare disruptions, significant distress, and general health. Results Mean self-efficacy for managing cancer was 7.58 out of 10. Greater self-efficacy was associated with lower odds for distress (OR 0.18 [95% CI 0.13–0.26], quartile 4 vs. 1) and for worse general health (0.05 [0.03–0.09]). Participants with disruptions to cancer-related healthcare had lower self-efficacy for managing cancer compared to those without (6.62 vs. 7.09, respectively, P < 0.001) and higher odds for distress (1.70 [1.36–2.14]), but not worse general health (1.13 [0.39–1.44]). Lower self-efficacy mediated 27% of the association between healthcare disruptions and increased distress (15–47%). Associations with self-efficacy for managing social interactions trended in the same direction. Conclusions During COVID-19, disruptions to cancer-related healthcare were associated with lower self-efficacy, increased distress, and worse general health. Psychosocial interventions designed to overcome barriers and target self-efficacy may be important for enhancing outcomes among cancer survivors experiencing disruptions in healthcare access.